Preimplantation genetic screening as an alternative to prenatal testing for Down syndrome: preferences of women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment

Fertility and Sterility

Volumn 88, Issue 4, 2007, Pages 804-810

  Twisk, Moniek ^a,b   Haadsma, Maaike L ^b   van der Veen, Fulco ^a   Repping, Sjoerd ^a   Mastenbroek, Sebastiaan ^a   Heineman, Maas Jan ^a,b   Bossuyt, Patrick M M ^a   Korevaar, Johanna C ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Down syndrome; in vitro fertilization; patient preferences; preimplantation genetic screening (PGS); prenatal diagnosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; GENETIC SCREENING; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PREGNANCY; PREGNANCY RATE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION;

ADULT; DOWN SYNDROME; FEMALE; FERTILIZATION IN VITRO; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFERTILITY, FEMALE; MALE; PREGNANCY; PREGNANCY RATE; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS; QUESTIONNAIRES; RISK; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 34848836080     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.12.033     Document Type: Article

References (29)

1. Penrose L.S. The relative effects of paternal and maternal age in mongolism. J Genet 27 (1933) 219
2. Kuliev A., Jackson L., Froster U., Brambati B., Simpson J.L., Verlinsky Y., et al. Chorionic villus sampling safety. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel-Aviv, Israel, May 21, 1994. Am J Obstet Gynecol 174 (1996) 807-811
3. Leschot N.J., Verjaal M., and Treffers P.E. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies. Br J Obstet Gynaecol 92 (1985) 804-807
4. Tabor A., Philip J., Madsen M., Bang J., Obel E.B., and Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1 (1986) 1287-1293
5. Cuckle H.S., Wald N.J., and Lindenbaum R.H. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1 (1984) 926-929
6. Nicolaides K.H., Azar G., Byrne D., Mansur C., and Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304 (1992) 867-869
7. Haddow J.E., Palomaki G.E., Knight G.J., Williams J., Miller W.A., and Johnson A. Screening of maternal serum for fetal Down's syndrome in the first trimester. N Engl J Med 338 (1998) 955-961
8. Spencer K., Spencer C.E., Power M., Dawson C., and Nicolaides K.H. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 110 (2003) 281-286
9. Kenyon S.L., Hackett G.A., and Campbell S. Termination of pregnancy following diagnosis of fetal malformation: the need for improved follow-up services. Clin Obstet Gynecol 31 (1988) 97-100
10. Gottlieb S. Doctors may be able to detect Down's syndrome during IVF. BMJ 323 (2001) 67
11. Staessen C., Platteau P., Van Assche E., Michiels A., Tournaye H., Camus M., et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19 (2004) 2849-2858
12. Munne S., Alikani M., Tomkin G., Grifo J., and Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 64 (1995) 382-391
13. Gianaroli L., Magli M.C., and Ferraretti A.P. The in vivo and in vitro efficiency and efficacy of PGD for aneuploidy. Mol Cell Endocrinol 183 Suppl 1 (2001) S13-S18
14. Munne S., Fischer J., Warner A., Chen S., Zouves C., and Cohen J. Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multicenter study. Fertil Steril 85 (2006) 326-332
15. Munne S., Magli C., Bahce M., Fung J., Legator M., Morrison L., et al. Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22. Prenat Diagn 18 (1998) 1459-1466
16. Sermon K., Moutou C., Harper J., Geraedts J., Scriven P., Wilton L., et al. ESHRE PGD Consortium data collection IV: May-December 2001. Hum Reprod 20 (2005) 19-34
17. Verlinsky Y., Cohen J., Munne S., Gianaroli L., Simpson J.L., Ferraretti A.P., and Kuliev A. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil Steril 82 (2004) 292-294
18. Twisk M., Mastenbroek S., van Wely M., Heineman M., van der Veen F., and Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev (2006) (issue 1)
19. Chamayou S., Guglielmino A., Giambona A., Siciliano S., Di Stefano G., Scibilia G., et al. Attitude of potential users in Sicily towards preimplantation genetic diagnosis for beta-thalassaemia and aneuploidies. Hum Reprod 13 (1998) 1936-1944
20. Snowdon C., and Green J.M. Preimplantation diagnosis and other reproductive options: attitudes of male and female carriers of recessive disorders. Hum Reprod 12 (1997) 341-350
21. Miedzybrodzka Z., Templeton A., Dean J., Haites N., Mollison J., and Smith N. Preimplantation diagnosis or chorionic villus biopsy? Women's attitudes and preferences. Hum Reprod 8 (1993) 2192-2196
22. Palomba M.L., Monni G., Lai R., Cau G., Olla G., and Cao A. Psychological implications and acceptability of preimplantation diagnosis. Hum Reprod 9 (1994) 360-362
23. Pergament E. Preimplantation diagnosis: a patient perspective. Prenat Diagn 11 (1991) 493-500
24. Lavery S.A., Aurell R., Turner C., Castello C., Veiga A., Barri P.N., et al. Preimplantation genetic diagnosis: patients' experiences and attitudes. Hum Reprod 17 (2002) 2464-2467
25. Hui P.W., Lam Y.H., Chen M., Tang M.H., Yeung W.S., Ng E.H., and Ho P.C. Attitude of at-risk subjects towards preimplantation genetic diagnosis of alpha- and beta-thalassaemias in Hong Kong. Prenat Diagn 22 (2002) 508-511
26. Meschede D., Lemcke B., Stussel J., Louwen F., and Horst J. Strong preference for non-invasive prenatal diagnosis in women pregnant through intracytoplasmic sperm injection (ICSI). Prenat Diagn 18 (1998) 700-705
27. Geipel A., Berg C., Katalinic A., Ludwig M., Germer U., Diedrich K., et al. Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod Biomed Online 8 (2004) 119-124
28. Thilaganathan B., Slack A., and Wathen N.C. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome. Ultrasound Obstet Gynecol 10 (1997) 261-264
29. Hackshaw A.K., and Wald N.J. Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening. Prenat Diagn 21 (2001) 741-746